Vaccination of stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

Cancer Immunology, Immunotherapy

Volumn 51, Issue 1, 2002, Pages 9-14

  Maio, Michele ^a   Fonsatti, Ester ^a   Lamaj, Elda ^a   Altomonte, Maresa ^a   Cattarossi, Ilaria ^a   Santantonio, Cristina ^a   Melani, Cecilia ^b   Belli, Filiberto ^b   Arienti, Flavio ^b   Colombo, Mario P ^b   Parmiani, Giorgio ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Antibodies; Cellular vaccines; Immunotherapy; Melanoma

Indexed keywords

ALLOANTIBODY; ANTISERUM; HLA A3 ANTIBODY; HLA A3 ANTIGEN; HLA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ALLELE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSDUCTION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNIZATION; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; TITRIMETRY; VACCINATION;

ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CANCER VACCINES; GENE THERAPY; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOTHERAPY; INTERLEUKIN-2; INTERLEUKIN-4; MELANOMA; NEOPLASM TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TRANSPLANTATION, HOMOLOGOUS; TUMOR STEM CELLS;

EID: 0036181209     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-001-0249-z     Document Type: Article

References (21)

1. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells
2. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes
3. Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells
4. Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
5. Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: Evaluation of efficacy and tolerability
6. Active immunization of metastatic melanoma patients with IL-2 or IL-4 gene transfected, allogeneic melanoma cells
7. Expression of protectin (CD59) in human melanoma and its functional role in cell-and complement-mediated cytotoxicity
8. 17-25) peptide in HLA-A3.1 melanoma patients
9. Rejection of mouse melanoma elicited by local secretion of interleukin-2: Implicating macrophages without T cells or natural killer cells in tumor rejection
10. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
11. Generation and analysis of interleukin-4 deficient mice
12. Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: Three consecutive stages may be required for successful tumor vaccination
13. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders
14. A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotype
15. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma
16. Cancer vaccines
17. Cytokine gene transduction in the immunotherapy of cancer
18. Immunological gene therapy with ex vivo gene-modified tumor cells: A critique and a reappraisal
19. Identification of the genes encoding cancer antigens: Implications for cancer immunotherapy
20. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice
21. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4